• Building healthcare business to accelerate digital transformation leveraging AI platform, product, and applications. • Serve customers across the healthcare value chain - Pharma, Med Device, Payers, and Providers.

• Deliver insights for clients for Series A/B start-ups, Venture Capital, and global multinationals on commercial idea generation, business and partnership models, equity fundraising, venture diligence, scale-up manufacturing, and capital investment decision making in the synthetic biology market.

• Exceeded growth and profit targets for ~$950m healthcare services business with ~3900 employees across 7 countries from Canada to Chile focused on managing chronic diseases including COPD, diabetes, sleep, wound care, and other respiratory complications from viral infections. Delivered 130% of ROIC target over 4 years.• Led Health Cloud digital health implementation to improve patient record management, deliver personalized care, and automate operations.• Turned around Brazil and Canada operations improving ROIC by 10%.• Designed and implemented value-based home healthcare and digital health strategy driving additional $50m in revenue.• Executed two strategic acquisitions (neonatal monitoring devices, home care services) and one divestiture (clinical services)

• Delivered shift in revenue growth trajectory from 2-3% to 8-9% adding $3B+ in value over 3 years.• Developed and implemented growth strategy enabling transformation towards integrated cancer care.• Drove $3B+ of deals including $600m VAREX Imaging spin-off of x-ray components and software.• Wrote digital health strategy and prioritized investments in treatment planning, proton therapy, and translational biology R&D programs.• Identified, cultivated, and signed $1.3B acquisition of Sirtex Medical radioembolization.• Managed venture capital equity investment portfolio focused on interventional radiology, molecular diagnostics, radiopharmaceutical and digital health.• Completed 4 equity investments (ABK Biomedical - led $30m Series B, Arterys - $25M Series B,Fusion Pharma - $46M Series A, Grail – investment in $900M+ Series B).

• Built product marketing team and cultivated partnerships to develop molecule and application strategy for synthetic biology innovator that used a unique algae-based biotechnology platform to produce tailored and renewable oil derived from plant based sugars.• Built comprehensive three-year product portfolio launch plan to introduce 10 molecules and 45 applications.• Developed brand and corporate strategy in support of $300M post IPO capital raise.

Client leadership: • Advised a wide range of C-suite clients in biopharma, medical technology, and private equity on innovation, commercial effectiveness, and growth strategy investments. • Led corporate transformation for a $30B MedTech client, resulting in acquisitions valued at $5-8B and divesting 30% of the business. This initiative delivered significant cost savings of $3.5B, reallocated the R&D portfolio, and successfully launched a new $3B interventional business.• Cultivated three new clients focused on clean tech investments. • Ran multiple teams simultaneously across the globe for four different clients. Delivered $750M incremental value per year via shift in R&D portfolio investments, improved salesforce operations, and M&A.People leadership: • Led recruiting for Mid-Atlantic offices. Trained over 400 new associates on problem solving and team management approaches.Thought leadership: • Devised and directed two different year-long knowledge efforts in climate change. • Conducted research and published on the impact of climate change and adaptation approaches sponsored by the Swiss Re, Rockefeller Foundation, World Bank and the United Nations in China, India, Guyana, Mali, and Florida.Social Sector Impact: • Led pro bono work for Mayor Cory Booker of Newark on efficient and effective government. • Led Gates Foundation work to prioritize HIV/AIDS intervention investments.

• MBA Summer Marketing Internship working on oncology and cardiovascular drug franchises.

• Identified, developed, negotiated, and led process and technology implementations for multinational clients in semiconductor and biopharma industries.• Led project teams of 150+ on global, multi-year business process improvement and software implementations focused on sales, marketing, and distribution.• Certified SAP trainer focused on sales, distribution and supply chain operations